MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to identify the optimal dose of voriconazole, an
anti-fungal drug often used in people undergoing stem cell transplant. An optimal dose level
is one level that provides a good blood level (concentration) of voriconazole without too
much toxicity.